About 4 results found for searched term "PI3Kδ-IN-14" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M43398 | PI3Kδ-IN-14 | PI3K |
| PI3Kδ-IN-14 is a selective PI3Kδ inhibitor (IC50: 0.8 nM, Kd: 84.8 nM). | ||
| M20632 | Selective PI3Kδ Inhibitor 1 (compound 7n) | PI3K |
| Selective PI3Kδ Inhibitor 1 (compound 7n) is an inhibitor of PI3Kδ with an IC50 of 0.9 nM and >1000-fold selectivity against other class I PI3K isoforms [PI3K α/γ/β=3670/1460/21300 nM]. | ||
| M28143 | Roginolisib | PI3K |
| MSC2360844; IOA-244 | ||
| Roginolisib (MSC2360844; IOA-244) is a potent, orally active and selective PI3Kδ inhibitor, with an IC50 of 145 nM. Roginolisib shows highly selective against a panel of 278 additional kinases. | ||
| M28709 | Roginolisib hemifumarate | PI3K |
| MSC2360844 hemifumarate; IOA-244 hemifumarate | ||
| Roginolisib (MSC2360844) hemifumarate is a potent, orally active and selective PI3Kδ inhibitor, with an IC50 of 145 nM. Roginolisib hemifumarate shows highly selective against a panel of 278 additional kinases. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
